Director/PDMR Shareholding

RNS Number : 9177D

GlaxoSmithKline PLC

02 May 2017

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	SVP, Human Resources
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The exercise of a nil-cost option over Ordinary Shares granted on 20 March 2014 and, as previously announced, was adjusted for performance and vested on 20 March 2017 under the Company's 2009 Deferred Annual Bonus Plan- Matching Award associated with a post-tax bonus deferral.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£0.0000	989
d)	Aggregated information	n/a single transaction
	Aggregated volume Price
e)	Date of the transaction	2017-04-28
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	SVP, Human Resources
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of Ordinary Shares to meet tax liabilities on a nil-cost option over Ordinary Shares exercised on 28 April 2017 under the Company's Deferred Annual Bonus Plan - Matching Award associated with a post-tax bonus deferral.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£15.5450	467
d)	Aggregated information	n/a single transaction
	Aggregated volume Price
e)	Date of the transaction	2017-04-28
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHLLLFBDEFBBBF